What smart money is saying about CellaVision
CEVI.ST
No fund has written a full thesis on CellaVision in our archive, but 1 fund letter reports a position in it, most recently Harding Loevner International Small Companies Equity in September 2026.
Get an email when a fund buys, sells or pitches it
1
Reported positions
0
Bought
0
Sold
1
Letter
Position history
Every position in CellaVision on record in the archive was reported in Q3 2026, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 1 position
- September 2026
“Returns were also strong in Sweden. CellaVision, which sells equipment that automates microscopic blood analysis, returned to organic growth in its fiscal second quarter after a disappointing period of customer inventory adjustments.”
CellaVision
Read the letters behind these CellaVision positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→Share this ledger